MedPath

A cohort study of integrated Chinese and Western medicine in the treatment of patients with chronic heart failure

Early Phase 1
Conditions
chronic heart failure
Registration Number
ITMCTR2024000079
Lead Sponsor
Affiliated Hospital to Changchun University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for chronic heart failure in the National Heart Failure Guidelines 2023 ;
2. Aged 18 years and above;
3. Those who gave informed consent to participate in the study voluntarily.

Exclusion Criteria

1. Patients with acute heart failure;
2. Patients with major life-affecting diseases such as respiratory failure and malignant tumours;
3. Patients with mental illness, cognitive decline and other conditions that affect communication;
4. Patients with severe liver or kidney function impairment, allergies or multiple drug allergies;
5. Patients with no access to medical information or missing information;
6. Patients who have lost visits;
7. Patients after heart transplantation.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of staged progression of heart failure;Heart failure readmission rates;cardiovascular endpoint event;
Secondary Outcome Measures
NameTimeMethod
Change from baseline in LVEF;Change from baseline in NT-proBNP;Changes in home and hospitalization from baseline;Change from baseline in 6-minute walk test;
© Copyright 2025. All Rights Reserved by MedPath